This research is a randomized smoking cessation trial conducted within and specifically personalized for lung cancer screening patients presenting to a lung screening clinic. Novel tobacco treatments for this population are critically needed, given the growing population of lung screening patients, which will grow dramatically now that lung screening is an approved CMS benefit. In the proposed study, we will test a gain-framed messaging intervention specifically designed for lung screening patients (vs. unframed messaging), as well as evaluating NRT sampling (vs. no medication) at 2 study sites. Our project is designed to be translational (in that it can be transferable from our controlled efficacy study to other lung screening programs).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
367
Gain-framed messaging materials
Unframed smoking cessation materials
Yale Cancer Center
New Haven, Connecticut, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Smoking Cessation - Available Data
Gain-framed messaging vs. Unframed messaging. 7-day, self-reported abstinence from cigarettes at the 6- month follow-up visit
Time frame: 6 month follow-up
Cigarettes Smoked Per Day - Average
Gain-framed messaging vs. Unframed messaging - average reported cigarettes smoked per day.
Time frame: 6 month follow-up
Smoking Cessation - Imputed
Gain-framed messaging vs. Unframed messaging. 7-day, self-reported abstinence from cigarettes at the 6- month follow-up visit. Missing participant data imputed to no cessation. 3 participants from the unframed group were not included as they had died prior to the 6-month visit.
Time frame: 6 Month Follow up Visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.